Terumo BCT and Terumo Corporation, our parent company, are closely monitoring the current outbreak of coronavirus disease (COVID-19). Our preparations and response are guided by our mission: Contributing to Society Through Healthcare.
We are actively planning based on three principles:
Terumo BCT has strong business continuity plans to help ensure continued availability of our products that are used to treat critically ill patients and that collect and process blood and blood products. We know a safe, sustainable and readily available supply of blood is vital to those with serious conditions and diseases.
We can confirm that there is little disruption to our supply chain as a result of the pandemic. We have implemented safety precautions at our factories to ensure social distancing to protect our associates and are currently operating at sufficient levels to meet current demand. Read More